MM
Mayank Mamtani B. Riley Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
52%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Healthcare
Communication Services
Entertainment
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $42 |
44%
upside
| 1 | +0.14% |
0
%
| 1 Dec ‘25 3 days ago |
|
|
|
Buy
Reiterated
| $40 |
53%
upside
| 2 | +25% |
0
%
| 21 Nov ‘25 13 days ago |
|
|
|
Buy
Initiated
| $12 |
43%
upside
| 1 | +74% |
0
%
| 19 Nov ‘25 15 days ago |
|
|
|
Buy
Reiterated
| $16 |
134%
upside
| 1 | -8.1% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Reiterated
| $90 |
39%
upside
| 2 | +16% |
0
%
| 10 Nov ‘25 24 days ago |
|
|
|
Buy
Reiterated
| $74 |
66%
upside
| 2 | +23% |
0
%
| 1 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $560 |
3%
downside
| 1 | +33% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $105 |
84%
upside
| 1 | +60% |
0
%
| 23 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $55 |
74%
upside
| 1 | -1.2% |
0
%
| 17 Sep ‘25 2 months ago |
|
|
|
Buy
Initiated
| $28 |
48%
upside
| 1 | +38% |
0
%
| 12 Sep ‘25 2 months ago |
|